Clearpoint Neuro Stock Target Price
| CLPT Stock | USD 14.43 0.52 3.74% |
Clearpoint Neuro's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Clearpoint Stock price.
Clearpoint | Build AI portfolio with Clearpoint Stock |
Clearpoint Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clearpoint Neuro's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clearpoint Neuro could also be used in its relative valuation, which is a method of valuing Clearpoint Neuro by comparing valuation metrics of similar companies.Clearpoint Neuro is currently under evaluation in target price category among its peers.
Clearpoint Fundamentals
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.3 | ||||
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 372.66 M | ||||
| Shares Outstanding | 27.98 M | ||||
| Shares Owned By Insiders | 7.84 % | ||||
| Shares Owned By Institutions | 33.02 % | ||||
| Number Of Shares Shorted | 900 K | ||||
| Price To Earning | (3.36) X | ||||
| Price To Book | 15.33 X | ||||
| Price To Sales | 12.86 X | ||||
| Revenue | 31.39 M | ||||
| Gross Profit | 19.12 M | ||||
| EBITDA | (17.84 M) | ||||
| Net Income | (18.91 M) | ||||
| Cash And Equivalents | 45.14 M | ||||
| Cash Per Share | 1.84 X | ||||
| Total Debt | 3.57 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 10.33 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | (8.95 M) | ||||
| Short Ratio | 3.87 X | ||||
| Earnings Per Share | (0.70) X | ||||
| Price To Earnings To Growth | (0.46) X | ||||
| Target Price | 27.67 | ||||
| Number Of Employees | 115 | ||||
| Beta | 0.98 | ||||
| Market Capitalization | 403.75 M | ||||
| Total Asset | 39.19 M | ||||
| Retained Earnings | (191.37 M) | ||||
| Working Capital | 23.01 M | ||||
| Current Asset | 8.1 M | ||||
| Current Liabilities | 1.85 M | ||||
| Net Asset | 39.19 M |
About Clearpoint Neuro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.